Download this datacard
Overview
Lobbying Costs
500,000€ - 599,999€
Financial year: Dec 2022 - Nov 2023
Lobbyists (Full time equivalent)
6 Fte (10)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
The Global CEO Initiative on Alzheimer's Disease (CEOi)
EU Transparency Register
320304848476-75 First registered on 22 Dec 2022
Goals / Remit
The Global CEO Initiative on Alzheimer’s Disease (CEOi), founded in 2013, is an organization of private-sector leaders who have joined together to provide business leadership in the fight against Alzheimer’s. The CEOi believes that, during this era of aging populations, it will take visionary, coordinated, goal-oriented leadership of public and private leaders working together to solve our greatest challenges. It is convened by UsAgainstAlzheimer’s. Members consist of public and private healthcare organizations invested in healthy aging, brain health, and Alzhiemer's Disease research, policy and advocacy.
Main EU files targeted
Institute for Healthcare Improvement
Healthier Together - EU NCD Initiative
EU4Health
Horizon Europe
EU Cohesion Policy
NextGenerationEU: Recovery and Resilience Facility
European Green Deal
European Digital Strategy
Pharmaceutical Strategy for EuropeAddress
Head Office
The Global CEO Initiative on Alzheimer's Disease5614 Connecticut Ave NW #288
Washington, DC 20015
UNITED STATESEU Office
155 East Lancaster Ave
Wayne 19087
UNITED STATESWebsite
-
People
Total lobbyists declared
10
Employment time Lobbyists 100% 2 75% 2 50% 4 25% 2 Lobbyists (Full time equivalent)
6
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
A total of 10 individuals involved in the organization.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
UsAgainstAlzheimer's: https://www.usagainstalzheimers.org/
American Academy of Neurology Industry Roundtable MemberMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Dec 2022 - Nov 2023
Lobbying costs for closed financial year
500,000€ - 599,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
500,000€ - 599,999€
Other financial info
N/A
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
Social economy,Competitive European Industry: long-term and sustainable investment,Demographic challenges, family-work balance and youth transition,Disability,SME
Communication activities
• We have developed and published thought pieces on accelerated approval in US and how this informs strategies in Europe as it relates to Alzheimer's and brain health.
• Support and engage in Alzheimer's and brain health advocacy activities across Europe including partnership with World Economic Forum, OECED, Alzheimer's International and European Brain Council
• Convene global Alzheimer's research and policy conference, Lausanne Workshop. This is convened by Alzheimer's Disease International, OECD, and the World Economic Forum. To identify unmet solutions in brain health, aging, and Alzheimer's research and care.
• Ongoing collaboration with the World Health Organization on their dementia policy plan
Host round table series on areas of research and innovation in brain health and Alzheimer's with speakers from industry, policy, and advocacy organizations.Other activities
None declared
Meetings
Meetings
None declared